The Human Genome Editing Race: Loosening Regulatory Standards for Commercial Advantage?
Sign Up to like & getrecommendations! Published in 2019 at "Trends in biotechnology"
DOI: 10.1016/j.tibtech.2018.06.005
Abstract: Medicinal products based on genome editing must undergo rigorous preclinical testing and are subject to regulatory oversight for proper risk assessment prior to first evaluation in humans. We give a European perspective on the regulatory… read more here.
Keywords: genome editing; race loosening; human genome; editing race ... See more keywords